Clinical trial
A Prospective Open Controlled Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors
NCT05856500 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Open Controlled Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 152 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
stage iii esophageal cancer, stage iiia gastric cancer, stage iiib gastric cancer, stage iv esophageal cancer, stage iv gastric cancer